SXI Life Sciences
7.528,07
PKT
+81,92
PKT
+1,10
%
Werbung
Analysen zu SXI Life Sciences-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 06.01.23 | Roche Outperform | Credit Suisse Group | |
| 06.01.23 | Novartis Underperform | Credit Suisse Group | |
| 06.01.23 | Novartis Underweight | Morgan Stanley | |
| 05.01.23 | Novartis Buy | Jefferies & Company Inc. | |
| 05.01.23 | Roche Hold | Jefferies & Company Inc. | |
| 03.01.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 03.01.23 | Novartis Neutral | JP Morgan Chase & Co. | |
| 23.12.22 | Novartis Underweight | Barclays Capital | |
| 23.12.22 | Roche Overweight | Barclays Capital | |
| 14.12.22 | Novartis Neutral | UBS AG | |
| 14.12.22 | Roche Neutral | UBS AG | |
| 12.12.22 | Novartis Buy | Jefferies & Company Inc. | |
| 09.12.22 | Novartis Sell | Deutsche Bank AG | |
| 08.12.22 | Novartis Market-Perform | Bernstein Research | |
| 08.12.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 07.12.22 | Novartis Sell | Deutsche Bank AG | |
| 06.12.22 | Novartis Neutral | UBS AG | |
| 02.12.22 | Roche Hold | Deutsche Bank AG | |
| 22.11.22 | Novartis Sell | Deutsche Bank AG | |
| 15.11.22 | Roche Hold | Deutsche Bank AG | |
| 14.11.22 | Roche Outperform | Credit Suisse Group | |
| 14.11.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 14.11.22 | Roche Overweight | Barclays Capital | |
| 14.11.22 | Roche Buy | Jefferies & Company Inc. | |
| 14.11.22 | Roche Neutral | UBS AG | |
| 14.11.22 | Roche Outperform | Bernstein Research | |
| 01.11.22 | Roche Hold | Deutsche Bank AG | |
| 27.10.22 | Novartis Sell | Deutsche Bank AG | |
| 26.10.22 | Novartis Market-Perform | Bernstein Research | |
| 26.10.22 | Novartis Underperform | Credit Suisse Group | |
| 26.10.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 26.10.22 | Novartis Underweight | Barclays Capital | |
| 25.10.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 25.10.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 25.10.22 | Novartis Sell | Deutsche Bank AG | |
| 25.10.22 | Novartis Neutral | UBS AG | |
| 25.10.22 | Novartis Buy | Jefferies & Company Inc. | |
| 24.10.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 21.10.22 | BB Biotech Add | Baader Bank | |
| 21.10.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. |